Glyphic Biotechnologies focuses on advancing the field of proteomics by developing a unique protein sequencing platform. This platform enables researchers to analyze proteins in detail, which helps them understand biological processes and diseases better. The technology works by providing advanced sequencing services that allow for in-depth study of protein structures and functions. Unlike other companies in the biotechnology sector, Glyphic Biotechnologies emphasizes a next-generation approach to protein sequencing, aiming to deliver insights that are not available through traditional methods. The company's goal is to enhance biological and medical research by providing tools that facilitate a deeper understanding of proteins and their roles in health and disease.